Healthcare Industry News: Thoracic Aortic Aneurysm
News Release - September 26, 2012
Bolton Medical Receives FDA Approval for the Relay(R) Thoracic Stent-Graft, a Minimally-Invasive Treatment for Thoracic Aortic Aneurysms and Penetrating UlcersSUNRISE, FL--(Healthcare Sales & Marketing Network) - Bolton Medical announced today that they have received approval from the U.S. Food and Drug Administration for the Relay Thoracic Stent-Graft with Plus Delivery System.
Specifically designed for the thoracic aorta, the Relay device is offered in a wide range of sizes to help to expand the use of this minimally-invasive treatment for Thoracic Aortic Aneurysms and penetrating atherosclerotic ulcers.
Bolton Medical stent-grafts have been widely used in Europe and other international markets since 2005 and, to date, more than 7,000 Relay and Relay NBS Thoracic Stent-Grafts have been implanted worldwide. The U.S. pivotal study included 120 endovascular patients at 30 hospitals across the country.
National Principal Investigator, Dr. Mark Farber, Director, UNC Aortic Center; Vascular Surgery Program Director; Associate Professor of Surgery and Radiology stated, "The Relay Thoracic Stent-Graft allows for precision and conformability, especially in patients with more challenging anatomies. As a physician, I find that the Relay device makes it easier for me to offer this life-saving treatment to a broader population of patients suffering from Thoracic Aortic Aneurysm."
The Relay system offers the following features:
- Distinct performance zones provide varying levels of radial support and apposition.
- Four-step dual sheath delivery system.
- Wide range of sizes to meet patient needs: lengths of 100mm-250mm, diameters of 22-46mm, straight and tapered.
Bolton Medical currently manufactures Relay and Relay NBS Thoracic Stent-Grafts. They are used worldwide for the treatment of main thoracic aortic pathologies. To date, approximately 7,000 Relay and Relay NBS Thoracic Stent-Grafts have been implanted worldwide. Bolton Medical is a private company, with European operations based in Barcelona, Spain, and U.S. operations in Sunrise, Florida. Bolton Medical is a wholly-owned subsidiary of the Werfen Life Group, a diverse manufacturer and supplier of products for the medical industry.
For more information on Relay Thoracic Stent-Graft with Plus Delivery System, please visit www.boltonmedical.com.
Source: Bolton Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.